Nevertheless, the SIRT3 protective effect was reverted when LCAD was simultaneously downregulated and/or a prooxidant cell environment was created (p < 0.001 vs. SIRT3 overexpressing cells with or without tBHP) (Figure 4C). The gene discussed is SIRT3; the disease is long chain acyl-CoA dehydrogenase deficiency.